Presbia PLC (NASDAQ:LENS) – Research analysts at Jefferies Group lowered their FY2019 earnings estimates for Presbia PLC in a report released on Monday. Jefferies Group analyst R. Denhoy now forecasts that the brokerage will post earnings per share of $0.13 for the year, down from their previous estimate of $0.14. Jefferies Group currently has a “Market Outperform” rating on the stock. Jefferies Group also issued estimates for Presbia PLC’s FY2020 earnings at $1.05 EPS.

Several other analysts have also recently weighed in on LENS. TheStreet cut Presbia PLC from a “hold” rating to a “sell” rating in a research report on Thursday, September 1st. Zacks Investment Research raised Presbia PLC from a “sell” rating to a “hold” rating in a research report on Tuesday, July 26th. Finally, Rodman & Renshaw set a $14.00 price target on Presbia PLC and gave the stock a “buy” rating in a research report on Thursday, July 21st.

Presbia PLC (NASDAQ:LENS) traded down 1.57% during mid-day trading on Wednesday, reaching $4.40. The company’s stock had a trading volume of 716 shares. Presbia PLC has a 12-month low of $2.94 and a 12-month high of $6.89. The firm’s market cap is $58.68 million. The company has a 50-day moving average price of $4.43 and a 200-day moving average price of $4.53.

About Presbia PLC

Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company’s segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States.

5 Day Chart for NASDAQ:LENS

Receive News & Stock Ratings for Presbia PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Presbia PLC and related stocks with our FREE daily email newsletter.